Inogen (INGN) Non-Current Assets (2013 - 2026)
Inogen's (INGN) quarterly Non-Current Assets came in at $91.4 million in Q2 2026, down 16.05% year-over-year from $108.9 million in Q2 2025, and down 4.02% quarter-over-quarter from $95.3 million in Q1 2026.
Analysis
Inogen (INGN) Non-Current Assets (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Non-Current Assets for 14 consecutive years, with $91.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 16.05% year-over-year to $91.4 million in Q2 2026; TTM through Jun 2026 was $390.3 million, a 11.49% decrease from a year earlier, with the FY2025 full-year figure at $100.3 million, down 9.4% from the prior year.
- Non-Current Assets was $91.4 million for Q2 2026 at Inogen, down from $95.3 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $156.5 million in Q1 2022 and troughed at $91.4 million in Q2 2026.
- A 5-year average of $115.0 million and a median of $109.8 million in 2024 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets sank 37.38% in 2022 and increased 18.66% in 2023, its largest moves.
- Over 5 years, Non-Current Assets stood at $100.4 million in 2022, then grew by 18.66% to $119.1 million in 2023, then dropped by 7.05% to $110.7 million in 2024, then dropped by 9.4% to $100.3 million in 2025, then fell by 8.86% to $91.4 million in 2026.
- The last three Non-Current Assets figures came in at $91.4 million (Q2 2026), $95.3 million (Q1 2026), and $100.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Inogen | 142.58 Mn | 37.04 Mn | 43.27 Mn | 91.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 91.44 Mn |
| Mar 31, 2026 | 95.26 Mn |
| Dec 31, 2025 | 100.33 Mn |
| Sep 30, 2025 | 103.29 Mn |
| Jun 30, 2025 | 108.92 Mn |
| Mar 31, 2025 | 107.70 Mn |
| Dec 31, 2024 | 110.73 Mn |
| Sep 30, 2024 | 113.62 Mn |
| Jun 30, 2024 | 114.13 Mn |
| Mar 31, 2024 | 116.41 Mn |
| Dec 31, 2023 | 119.13 Mn |
| Sep 30, 2023 | 118.43 Mn |
| Jun 30, 2023 | 105.13 Mn |
| Mar 31, 2023 | 102.53 Mn |
| Dec 31, 2022 | 100.40 Mn |
| Sep 30, 2022 | 151.81 Mn |
| Jun 30, 2022 | 154.62 Mn |
| Mar 31, 2022 | 156.49 Mn |
| Dec 31, 2021 | 160.33 Mn |
| Sep 30, 2021 | 177.03 Mn |